
TC BioPharm and bluebird bio team up for gamma delta CART therapies
Executive Summary
TC BioPharm Ltd. and bluebird bio Inc. penned a deal for the discovery and development of CAR-engineered gamma T-cell therapies for cancer.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com